iron glycinate
Small moleculeexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
2
Phase 4
0
Earliest trial started Oct 1, 2010 (NCT01160198)
Timeline
Indications
Mechanism of action
- IronSupplementation
Iron supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ferrous bisglycinate
- ferrous bisglycinate
- ferrous bisglycinate
- ferrous bisglycinate
- ferrous bis-glycinate
- ferrous glycinate
- iron bisglycinate
- iron bisglycinate
- iron bisglycinate
- iron glycinate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03009578 | Phase 3 | Feb 1, 2017 | Assiut University |
| NCT02458625 | N/A | Apr 1, 2016 | Emek Medical Center |
| NCT02590224 | Phase 2 | Jan 1, 2016 | Assiut University |
| NCT01160198 | Phase 3 | Oct 1, 2010 | GlaxoSmithKline |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Assiut University | Academic/Hospital | 2 | 2 | 2 | 2016 |
| Emek Medical Center | Academic/Hospital | 1 | 1 | 1 | 2016 |
| GlaxoSmithKline | For profit | 1 | 1 | 1 | 2010 |
3 organizations
Page 1 / 1